BioSkryb Genomics

Durham, United States

BioSkryb Genomics is a rapidly growing organization that is transforming single cell molecular discovery and analysis.

Mar 2022

Convertible Note

Biotechnology Life Science

Top Investors

Anzu PartnersWilson Sonsini Goodrich & Rosati

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BioSkryb Genomics

Who are BioSkryb Genomics's investors?

BioSkryb Genomics's investors include Anzu Partners, Wilson Sonsini Goodrich & Rosati.

Where is BioSkryb Genomics headquartered?

BioSkryb Genomics is headquartered in Durham, United States.

What does BioSkryb Genomics do?

BioSkryb Genomics is a rapidly growing organization that is transforming single cell molecular discovery and analysis.

What stage is BioSkryb Genomics at?

BioSkryb Genomics is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 3, 2022.

MLA

"BioSkryb Genomics — Funding & Investors." VCBacked, March 3, 2022, https://www.vcbacked.co/company/bioskryb-genomics. Accessed July 1, 2026.

APA

VCBacked. (2022). BioSkryb Genomics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/bioskryb-genomics

Wikipedia (cite web)

{{cite web |title=BioSkryb Genomics — Funding & Investors |url=https://www.vcbacked.co/company/bioskryb-genomics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 3, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.